You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glomerulonephritis, Membranous

Showing 1 - 25 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Biomarker in Membranous Glomerulonephritis

Not yet recruiting
  • Membranous Nephropathy
  • urinary markers
  • (no location specified)
Jan 18, 2023

Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Not yet recruiting
  • Glomerulonephritis, IGA
  • +4 more
  • Microscopic hyperspectral imaging system
  • (no location specified)
Mar 31, 2023

Idiopathic Membranous Nephropathy

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • Obinutuzumab Injection
  • (no location specified)
May 8, 2023

High Incidence of Thrombotic Events in Patients With MN and DKD

Active, not recruiting
  • Glomerulonephritis, Membranous
  • +3 more
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Dec 7, 2022

Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
May 16, 2023

T- and B-Cell Subpopulations in Membranous Nephropathy

Recruiting
  • Membranous Nephropathy
  • +2 more
    • Istanbul, Turkey
      Istanbul University
    May 31, 2023

    Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

    Recruiting
    • Nephrotic Syndrome
    • +4 more
    • Rituximab Infusion
    • Oral Cyclosporine
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)

    Not yet recruiting
    • Glomerulonephritis, Membranous
    • Nephrotic Syndrome，Idiopathic
    • Rituximab (genetical recombination)
    • Placebo
    • Anjo, Aichi, Japan
    • +7 more
    Jun 13, 2023

    Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

    Not yet recruiting
    • Membranous Nephropathy
    • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
    • Nice, France
      CHU de NICE
    Jul 4, 2023

    Prognostic Model of Rituximab in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    Prognostic Model of TAC in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)

    Recruiting
    • Idiopathic Membranous Nephropathy
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Mar 23, 2023

    Primary Membranous Nephropathy Trial (EVER001)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • (no location specified)
    Mar 23, 2023

    Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system

    Not yet recruiting
    • Nephropathy
    • +2 more
    • Huaier granule
    • +2 more
    • (no location specified)
    Apr 20, 2023

    PLA2R-IgG4 Detection Kit

    Enrolling by invitation
    • Membranous Nephropathy - PLA2R Induced
    • Kidney Diseases-except Membranous Nephropathy
      • Hangzhou, China
        ZhejiangBiostar
      May 6, 2023

      Prognostic Model of GC/CTX in the Treatment of MN

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • glucocorticoid + cytoxan
      • (no location specified)
      Dec 28, 2022

      Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • glucocorticoid + tacrolimus
      • (no location specified)
      Dec 28, 2022

      Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)

      Recruiting
      • Membranous Nephropathy - PLA2R Induced
      • Rituximab, Cyclophosphamide, and Corticosteroids
      • Saint Petersburg, Russian Federation
        St. Petersburg State Pavlov Medical University
      Jan 7, 2023

      Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

      Not yet recruiting
      • Primary Membranous Nephropathy
      • (no location specified)
      Jan 23, 2023

      Idiopathic Membranous Nephropathy Trial in Beijing

      Recruiting
      • Idiopathic Membranous Nephropathy
        • Beijing, Beijing, China
        • +2 more
        Jan 18, 2023

        Hyperspectral Imaging Technique in CTX Treatment of IMN

        Not yet recruiting
        • Hyperspectral Imaging
        • +2 more
        • Microscopic hyperspectral imaging system
        • (no location specified)
        Apr 29, 2023

        Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy Trial (povetacicept)

        Not yet recruiting
        • Lupus Nephritis
        • +2 more
        • (no location specified)
        Feb 16, 2023

        Hyperspectral Imaging Technique in the Treatment of IMN by TAC

        Not yet recruiting
        • Idiopathic Membranous Nephropathy
        • +2 more
        • Tacrolimus for the treatment of IMN
        • (no location specified)
        Mar 31, 2023

        Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)

        Not yet recruiting
        • Primary Membranous Nephropathy
        • (no location specified)
        Jan 13, 2023

        Autoreactive B Cells in Membranous Nephropathy

        Recruiting
        • Membranous Nephropathy
        • In vitro assays.
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
        Nov 2, 2022